Sciact
  • EN
  • RU

Dehydroabietylamine Ureas and Thioureas as Tyrosyl-DNA Phosphodiesterase 1 Inhibitors That Enhance the Antitumor Effect of Temozolomide on Glioblastoma Cells Научная публикация

Журнал Journal of Natural Products
ISSN: 0163-3864
Вых. Данные Год: 2019, Том: 82, Номер: 9, Страницы: 2443-2450 Страниц : DOI: 10.1021/acs.jnatprod.8b01095
Авторы Kovaleva Kseniya 1,2 , Oleshko Olga 2 , Mamontova Evgeniya 3 , Yarovaya Olga 1,2 , Zakharova Olga 3 , Zakharenko Alexandra 3 , Kononova Alena 2 , Dyrkheeva Nadezhda 3 , Cheresiz Sergey 2,4 , Pokrovsky Andrey 2 , Lavrik Olga 2,3 , Salakhutdinov Nariman 1,2
Организации
1 (Данные Web of science) Russian Acad Sci, Siberian Branch, NN Vorozhtsov Novosibirsk Inst Organ Chem, Novosibirsk 630090, Russia
2 (Данные Web of science) Novosibirsk State Univ, Novosibirsk 630090, Russia
3 (Данные Web of science) Russian Acad Sci, Siberian Branch, Novosibirsk Inst Chem Biol & Fundamental Med, Novosibirsk 630090, Russia
4 (Данные Web of science) State Sci Res Inst Physiol & Basic Med, POB 237, Novosibirsk 630117, Russia

Реферат: A new class of tyrosyl-DNA phosphodiesterase 1 (TDP1) inhibitors was found among resin acid derivatives. Several novel ureas and thioureas derived from dehydroabietylamine were synthesized and tested for TDP1 inhibition. The synthesized compounds showed IC50 values in the range of 0.1 to 3.7 mu M and demonstrated low cytotoxicity against the human tumor cell lines U-937, U-87MG, MDA-MB, SK-Me18, A-549, MCF7, T98G, and SNB19. Several compounds showed enhancement of the cytotoxic activity of the alkylating agent temozolomide, which is used as a first line therapy against glioblastoma (GBM), in the GBM cell lines U-87MG and SNB19.
Библиографическая ссылка: Kovaleva K. , Oleshko O. , Mamontova E. , Yarovaya O. , Zakharova O. , Zakharenko A. , Kononova A. , Dyrkheeva N. , Cheresiz S. , Pokrovsky A. , Lavrik O. , Salakhutdinov N.
Dehydroabietylamine Ureas and Thioureas as Tyrosyl-DNA Phosphodiesterase 1 Inhibitors That Enhance the Antitumor Effect of Temozolomide on Glioblastoma Cells
Journal of Natural Products. 2019. V.82. N9. P.2443-2450. DOI: 10.1021/acs.jnatprod.8b01095 WOS Scopus РИНЦ OpenAlex
Даты:
Опубликована online: 20 авг. 2019 г.
Опубликована в печати: 27 сент. 2019 г.
Идентификаторы БД:
Web of science: WOS:000488424000009
Scopus: 2-s2.0-85071862995
РИНЦ: 41683948
OpenAlex: W2969529236
Цитирование в БД:
БД Цитирований
Web of science 20
Scopus 19
РИНЦ 23
OpenAlex 21
Альметрики: